▲ Peaking
Business
Biogen Alzheimer's drug slowed decline at rates on par with approved therapies, study shows
2sources
2articles
1velocity
-43%since first seen
just nowfirst detected
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Coverage (2)
- Can Biogen Convince Skeptics That Cutting a Rogue Protein Slows Alzheimer’s? Barron's · 4h ago
- An experimental Alzheimer's drug shows some promise as researchers hunt new approaches ABC News - Breaking News, Latest News and Videos · 4h ago
Related trends
▲ Peaking
Business
TSMC Sales Jump 36% as Memory Stocks Plunge. What It Means for NVIDIA and AMD
▲ Peaking
Business
US Stock Futures Fall as Mideast Tensions Flare Anew, Oil Climbs
▲ Peaking
Business
SpaceX Stock Is Only 3% Away From Complete Humiliation
▲ Peaking
Business
A Majority of Americans Now Support Seizing Wealth From AI Industry
▲ Peaking
Business
U.S. Workers Are More Productive Than Ever. A.I. Isn’t the Key.
U.S. worker productivity has reached record highs, but current data suggests AI is not the primary driver of this growth.
▲ Peaking
Business